Anticonvulsant effect of a ghrelin receptor agonist in 6Hz corneally kindled mice

Jessica Coppens1, Najat Aourz1, Laura Walrave1

  • 1Center for Neurosciences, VUB Free University Brussels, Brussels, Belgium.

Epilepsia
|July 6, 2016
PubMed

Insights

Ghrelin receptor deletion did not affect seizure development in mice. However, a ghrelin receptor agonist demonstrated anticonvulsant effects in kindled mice, indicating its therapeutic potential for seizure disorders.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Ghrelin exhibits anticonvulsant and neuroprotective properties.
  • The role of the ghrelin receptor in seizure development and its modulation by ligands remains unclear.

Purpose of the Study:

  • To investigate the impact of ghrelin receptor deletion on the kindling process.
  • To evaluate the anticonvulsant effects of ghrelin receptor ligands in a 6 Hz corneal kindling model.

Main Methods:

  • Utilized ghrelin receptor wild-type and knockout mice in a 6 Hz corneal kindling model.
  • Administered ghrelin receptor agonist (JMV-1843) and antagonist (JMV-2959) to assess anticonvulsant activity.

Main Results:

  • Ghrelin receptor knockout mice exhibited similar seizure severity to wild-type littermates during kindling acquisition and maintenance.
  • The ghrelin receptor agonist JMV-1843 reduced seizure severity in wild-type mice but not in knockout mice.
  • The ghrelin receptor antagonist JMV-2959 showed no effect on seizure severity in either model.

Conclusions:

  • Ghrelin receptor deletion does not influence the kindling process.
  • The anticonvulsant effects of JMV-1843 in kindled mice are mediated through the ghrelin receptor, suggesting its potential as an antiepileptic agent.

Related Concept Videos